The long-term efficacy and safety of apatinib are inferior to sorafenib in the first-line treatment of advanced hepatocellular carcinoma: A systematic review and meta-analysis
Article in Medicine (January 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Article in Medicine (January 2024)
Article in Frontiers in Oncology (May 2023)
Article in Hepatology International (April 2023)